한글목차

세계의 IV 플러쉬 시린지 시장 규모는 2024년에 5억 7,900만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 7.0%로 성장을 지속하여, 2031년까지 9억 2,900만 달러에 이를 것으로 예측됩니다.

본 보고서에서는 정맥주사기의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축에 대한 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.

IV 플러시 주사기는 정맥 접근 장치의 개통성을 유지하고 카테터 관련 합병증을 줄이기 위해 고안된 멸균 일회용 의료 소모품으로, 일회용 의료 소모품입니다. 미리 채워진 주사기로 제공되거나 프로토콜에 따라 진료 현장에서 준비되는 이 주사기는 표준화된 플러싱 용액을 공급하고, 카테터 세척, 혈전증 예방, 감염 위험 감소에 기여합니다. 주요 제품 특성으로는 멸균 포장, 복용량 표준화, 사용의 편리성을 들 수 있습니다. 이러한 특징은 조제 및 투약 시 오염 위험을 최소화하면서 임상 워크플로우를 개선할 수 있도록 도와줍니다. 감염 예방과 수액 안전이 핵심 품질 지표로 떠오르면서 IV 플러시 주사기는 일상적인 소모품에서 표준화된 치료 경로와 병원 조달 우선순위에 통합된 전략적 임상 안전 도구로 진화하고 있습니다. 2024년, 세계 IV 플래시 주사기 생산량은 약 10억 5,300만 개에 달했고, 세계 평균 시장 가격은 개당 약 0.55달러였습니다.

감염 예방과 수액 안전에 대한 규제 당국의 관심이 높아짐에 따라, 의료 서비스 제공업체들은 임상 프로토콜과 조달 프레임워크에서 일회용, 사전 충전된 표준화된 플러시 솔루션의 채택을 추진하고 있습니다. 이러한 정책적 요인이 IV 플래시 주사기에 대한 조직적인 수요를 창출하고 있습니다. 동시에 병원의 간호 효율성 향상, 준비 시간 단축, 인적 오류 최소화에 대한 요구는 수동 준비에서 시판되는 표준화된 제품으로의 전환을 가속화하고 있습니다. 주요 의료기기 및 소모품 제조업체들은 투자자 커뮤니케이션 및 연례 보고서에서 프리필드 플래시 솔루션의 생산 능력 확대와 제품 혁신을 최우선 전략으로 삼고 제조, 공급망 및 상업화 능력의 급속한 발전을 촉진하고 있습니다. 표준화된 포장과 추적성을 전자 재고 관리 시스템과 통합함으로써 구매자는 규정 준수와 비용의 균형을 더욱 쉽게 맞출 수 있으며, 지속 가능한 수요를 확대할 수 있습니다.

고품질 무균 생산과 안정적인 공급이 핵심 과제입니다. 프리필드 제제는 GMP 수준의 충전 능력과 강력한 공급망을 필요로 하며, 막대한 자본과 운영상의 노력이 필요하기 때문에 공급업체는 공급 충격 시 위험에 노출될 수 있습니다. 관할권별 규제의 불균일성은 국경을 넘나드는 전개를 복잡하게 만들고, 인증 부담을 증가시킵니다. 재료 적합성, 용액 안정성, 사용자 친화적 인 포장에 대한 임상적 기대는 지속적인 연구 개발과 엄격한 품질 관리를 필요로합니다. 마지막으로, 제품을 병원 정보 시스템 및 재고 워크플로우와 원활하게 통합하지 못하면 임상 도입이 지연되고 고객 유지율이 떨어질 수 있습니다.

다운스트림 조달은 임시 소모품 구매에서 통합 프로세스 지향 솔루션으로 전환하고 있습니다. 병원은 규제 적합성, 사용 편의성, 시스템 상호운용성 등을 기준으로 제품을 평가하는 경향이 강해지고 있으며, 교육, 모니터링, 품질 보증 서비스도 구매 결정의 중요한 요소로 작용하고 있습니다. 소아용 소용량 주사기, 화학요법 최적화 모델, 폐쇄형 시스템용 캡이 달린 주사기 등 시나리오에 특화된 포맷이 선호되는 추세입니다. 제조업체들은 제품 포트폴리오의 확대(예: 색상 구분 캡, 추적 가능한 바코드 등)와 도입 지원 서비스 제공을 통해 고객 가치를 높이고 있으며, 이는 고품질, 고수익률 제품에 대한 다운스트림 수요를 촉진하고 있습니다.

이 보고서는 IV 플래시 주사기 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도로 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하여 판매량(천 단위) 및 매출액(백만 달러)으로 IV 플러시 주사기 시장 규모를 추정 및 예측했습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, IV 플래시 주사기 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

• BD
• Medline
• Medefil
• B. Braun
• Cardinal Health
• Weigao Group
• Jiangsu Impex Technology
• Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
• Shandong Zhongbaokang
• Nam Kwang Chemical Pharmaceuticals
• Guangdong Aixide Pharmaceutical Co., Ltd.
• Guerbet
• Sterisets
• Aquabiliti

유형별 부문

• 생리식염수용 IV 플러쉬 시린지
• 헤파린 IV 플러쉬 시린지

용도별 부문

• 병원
• 진료소
• 기타

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for IV Flush Syringe was estimated to be worth US$ 579 million in 2024 and is forecast to a readjusted size of US$ 929 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on IV Flush Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An IV Flush Syringe is a sterile, single-use medical consumable designed to maintain the patency of venous access devices and reduce catheter-related complications. Whether provided as prefilled syringes or prepared at point-of-care per protocol, these syringes deliver standardized flush solutions to clear indwelling catheters, help prevent thrombosis, and lower infection risk. Key product attributes include sterile packaging, dose standardization, and ease of use-features that minimize contamination opportunities during preparation and administration while improving clinical workflow. As infection prevention and infusion safety have become central quality metrics, IV flush syringes are evolving from routine consumables into strategic clinical-safety tools integrated into standardized care pathways and hospital procurement priorities.In 2024, global IV Flush Syringe production reached approximately 1053 m units, with an average global market price of around US$ 0.55 perunit

Heightened regulatory emphasis on infection prevention and infusion safety is prompting healthcare providers to adopt single-use, prefilled, or standardized flush solutions within clinical protocols and procurement frameworks. These policy drivers create institutional demand for IV flush syringes. At the same time, hospitals' need to improve nursing efficiency, reduce preparation time, and minimize human error is accelerating the shift from manual preparation to commercially supplied, standardized products. Leading medtech and consumables companies have signalled in investor communications and annual reports that capacity expansion and product innovation in prefilled flush solutions are priority strategic initiatives-fostering rapid advances in manufacturing, supply chain, and commercialization capabilities. Integration of standardized packaging and traceability with electronic inventory systems further enables buyers to balance compliance and cost, enlarging sustainable demand.

High-quality sterile manufacturing and reliable supply are core challenges: prefilled solutions demand GMP-level filling capacity and resilient supply chains, requiring substantial capital and operational commitment and exposing suppliers to risk during supply shocks. Regulatory heterogeneity across jurisdictions complicates cross-border launches and adds to certification burdens. Clinical expectations around material compatibility, solution stability, and user-friendly packaging necessitate continuous R&D and rigorous quality control. Finally, failure to seamlessly integrate products with hospital information systems and inventory workflows can slow clinical adoption and reduce customer retention.

Downstream procurement is moving from ad-hoc consumable purchases toward integrated, process-oriented solutions: hospitals increasingly evaluate products based on regulatory credentials, ease of use, and system interoperability, while training, monitoring, and quality assurance services are becoming part of purchasing decisions. Scenario-specific formats-such as small-volume pediatric syringes, chemo-optimized variants, and syringes with closed-system caps-are gaining preference. Manufacturers are enhancing customer value by extending product portfolios (e.g., color-coded caps, traceable barcodes) and offering enablement services, which elevates downstream demand toward higher quality and higher-margin offerings.

This report aims to provide a comprehensive presentation of the global market for IV Flush Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IV Flush Syringe by region & country, by Type, and by Application.

The IV Flush Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IV Flush Syringe.

Market Segmentation

By Company

• BD
• Medline
• Medefil
• B. Braun
• Cardinal Health
• Weigao Group
• Jiangsu Impex Technology
• Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
• Shandong Zhongbaokang
• Nam Kwang Chemical Pharmaceuticals
• Guangdong Aixide Pharmaceutical Co., Ltd.
• Guerbet
• Sterisets
• Aquabiliti

Segment by Type

• Saline IV Flush Syringe
• Heparin IV Flush Syringe

Segment by Application

• Hospital
• Clinic
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of IV Flush Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of IV Flush Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of IV Flush Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 IV Flush Syringe Product Introduction
• 1.2 Global IV Flush Syringe Market Size Forecast
  • 1.2.1 Global IV Flush Syringe Sales Value (2020-2031)
  • 1.2.2 Global IV Flush Syringe Sales Volume (2020-2031)
  • 1.2.3 Global IV Flush Syringe Sales Price (2020-2031)
• 1.3 IV Flush Syringe Market Trends & Drivers
  • 1.3.1 IV Flush Syringe Industry Trends
  • 1.3.2 IV Flush Syringe Market Drivers & Opportunity
  • 1.3.3 IV Flush Syringe Market Challenges
  • 1.3.4 IV Flush Syringe Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global IV Flush Syringe Players Revenue Ranking (2024)
• 2.2 Global IV Flush Syringe Revenue by Company (2020-2025)
• 2.3 Global IV Flush Syringe Players Sales Volume Ranking (2024)
• 2.4 Global IV Flush Syringe Sales Volume by Company Players (2020-2025)
• 2.5 Global IV Flush Syringe Average Price by Company (2020-2025)
• 2.6 Key Manufacturers IV Flush Syringe Manufacturing Base and Headquarters
• 2.7 Key Manufacturers IV Flush Syringe Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of IV Flush Syringe
• 2.9 IV Flush Syringe Market Competitive Analysis
  • 2.9.1 IV Flush Syringe Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by IV Flush Syringe Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Flush Syringe as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Saline IV Flush Syringe
  • 3.1.2 Heparin IV Flush Syringe
• 3.2 Global IV Flush Syringe Sales Value by Type
  • 3.2.1 Global IV Flush Syringe Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global IV Flush Syringe Sales Value, by Type (2020-2031)
  • 3.2.3 Global IV Flush Syringe Sales Value, by Type (%) (2020-2031)
• 3.3 Global IV Flush Syringe Sales Volume by Type
  • 3.3.1 Global IV Flush Syringe Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global IV Flush Syringe Sales Volume, by Type (2020-2031)
  • 3.3.3 Global IV Flush Syringe Sales Volume, by Type (%) (2020-2031)
• 3.4 Global IV Flush Syringe Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Others
• 4.2 Global IV Flush Syringe Sales Value by Application
  • 4.2.1 Global IV Flush Syringe Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global IV Flush Syringe Sales Value, by Application (2020-2031)
  • 4.2.3 Global IV Flush Syringe Sales Value, by Application (%) (2020-2031)
• 4.3 Global IV Flush Syringe Sales Volume by Application
  • 4.3.1 Global IV Flush Syringe Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global IV Flush Syringe Sales Volume, by Application (2020-2031)
  • 4.3.3 Global IV Flush Syringe Sales Volume, by Application (%) (2020-2031)
• 4.4 Global IV Flush Syringe Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global IV Flush Syringe Sales Value by Region
  • 5.1.1 Global IV Flush Syringe Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global IV Flush Syringe Sales Value by Region (2020-2025)
  • 5.1.3 Global IV Flush Syringe Sales Value by Region (2026-2031)
  • 5.1.4 Global IV Flush Syringe Sales Value by Region (%), (2020-2031)
• 5.2 Global IV Flush Syringe Sales Volume by Region
  • 5.2.1 Global IV Flush Syringe Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global IV Flush Syringe Sales Volume by Region (2020-2025)
  • 5.2.3 Global IV Flush Syringe Sales Volume by Region (2026-2031)
  • 5.2.4 Global IV Flush Syringe Sales Volume by Region (%), (2020-2031)
• 5.3 Global IV Flush Syringe Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America IV Flush Syringe Sales Value, 2020-2031
  • 5.4.2 North America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe IV Flush Syringe Sales Value, 2020-2031
  • 5.5.2 Europe IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific IV Flush Syringe Sales Value, 2020-2031
  • 5.6.2 Asia Pacific IV Flush Syringe Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America IV Flush Syringe Sales Value, 2020-2031
  • 5.7.2 South America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa IV Flush Syringe Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa IV Flush Syringe Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions IV Flush Syringe Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions IV Flush Syringe Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions IV Flush Syringe Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions IV Flush Syringe Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States IV Flush Syringe Sales Value, 2020-2031
  • 6.3.2 United States IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe IV Flush Syringe Sales Value, 2020-2031
  • 6.4.2 Europe IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China IV Flush Syringe Sales Value, 2020-2031
  • 6.5.2 China IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan IV Flush Syringe Sales Value, 2020-2031
  • 6.6.2 Japan IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea IV Flush Syringe Sales Value, 2020-2031
  • 6.7.2 South Korea IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia IV Flush Syringe Sales Value, 2020-2031
  • 6.8.2 Southeast Asia IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India IV Flush Syringe Sales Value, 2020-2031
  • 6.9.2 India IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India IV Flush Syringe Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 BD
  • 7.1.1 BD Company Information
  • 7.1.2 BD Introduction and Business Overview
  • 7.1.3 BD IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 BD IV Flush Syringe Product Offerings
  • 7.1.5 BD Recent Development
• 7.2 Medline
  • 7.2.1 Medline Company Information
  • 7.2.2 Medline Introduction and Business Overview
  • 7.2.3 Medline IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Medline IV Flush Syringe Product Offerings
  • 7.2.5 Medline Recent Development
• 7.3 Medefil
  • 7.3.1 Medefil Company Information
  • 7.3.2 Medefil Introduction and Business Overview
  • 7.3.3 Medefil IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Medefil IV Flush Syringe Product Offerings
  • 7.3.5 Medefil Recent Development
• 7.4 B. Braun
  • 7.4.1 B. Braun Company Information
  • 7.4.2 B. Braun Introduction and Business Overview
  • 7.4.3 B. Braun IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 B. Braun IV Flush Syringe Product Offerings
  • 7.4.5 B. Braun Recent Development
• 7.5 Cardinal Health
  • 7.5.1 Cardinal Health Company Information
  • 7.5.2 Cardinal Health Introduction and Business Overview
  • 7.5.3 Cardinal Health IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cardinal Health IV Flush Syringe Product Offerings
  • 7.5.5 Cardinal Health Recent Development
• 7.6 Weigao Group
  • 7.6.1 Weigao Group Company Information
  • 7.6.2 Weigao Group Introduction and Business Overview
  • 7.6.3 Weigao Group IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Weigao Group IV Flush Syringe Product Offerings
  • 7.6.5 Weigao Group Recent Development
• 7.7 Jiangsu Impex Technology
  • 7.7.1 Jiangsu Impex Technology Company Information
  • 7.7.2 Jiangsu Impex Technology Introduction and Business Overview
  • 7.7.3 Jiangsu Impex Technology IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Jiangsu Impex Technology IV Flush Syringe Product Offerings
  • 7.7.5 Jiangsu Impex Technology Recent Development
• 7.8 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
  • 7.8.1 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Company Information
  • 7.8.2 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Introduction and Business Overview
  • 7.8.3 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • 7.8.5 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Recent Development
• 7.9 Shandong Zhongbaokang
  • 7.9.1 Shandong Zhongbaokang Company Information
  • 7.9.2 Shandong Zhongbaokang Introduction and Business Overview
  • 7.9.3 Shandong Zhongbaokang IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Shandong Zhongbaokang IV Flush Syringe Product Offerings
  • 7.9.5 Shandong Zhongbaokang Recent Development
• 7.10 Nam Kwang Chemical Pharmaceuticals
  • 7.10.1 Nam Kwang Chemical Pharmaceuticals Company Information
  • 7.10.2 Nam Kwang Chemical Pharmaceuticals Introduction and Business Overview
  • 7.10.3 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Product Offerings
  • 7.10.5 Nam Kwang Chemical Pharmaceuticals Recent Development
• 7.11 Guangdong Aixide Pharmaceutical Co., Ltd.
  • 7.11.1 Guangdong Aixide Pharmaceutical Co., Ltd. Company Information
  • 7.11.2 Guangdong Aixide Pharmaceutical Co., Ltd. Introduction and Business Overview
  • 7.11.3 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • 7.11.5 Guangdong Aixide Pharmaceutical Co., Ltd. Recent Development
• 7.12 Guerbet
  • 7.12.1 Guerbet Company Information
  • 7.12.2 Guerbet Introduction and Business Overview
  • 7.12.3 Guerbet IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Guerbet IV Flush Syringe Product Offerings
  • 7.12.5 Guerbet Recent Development
• 7.13 Sterisets
  • 7.13.1 Sterisets Company Information
  • 7.13.2 Sterisets Introduction and Business Overview
  • 7.13.3 Sterisets IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Sterisets IV Flush Syringe Product Offerings
  • 7.13.5 Sterisets Recent Development
• 7.14 Aquabiliti
  • 7.14.1 Aquabiliti Company Information
  • 7.14.2 Aquabiliti Introduction and Business Overview
  • 7.14.3 Aquabiliti IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Aquabiliti IV Flush Syringe Product Offerings
  • 7.14.5 Aquabiliti Recent Development

8 Industry Chain Analysis

• 8.1 IV Flush Syringe Industrial Chain
• 8.2 IV Flush Syringe Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 IV Flush Syringe Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 IV Flush Syringe Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer